CLASS II Device recall · Reported 28 Mar 2018 · FDA Enforcement Report

Malecot Nephrostomy Catheter Set, Product Number: M0064101000 recalled

Boston Scientific is recalling Malecot Nephrostomy Catheter Set, Product Number: M0064101000, distributed nationwide in the US. The recall was initiated on 12 Dec 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesExpiration Date Range: 1/22/2018 - 10/24/2021; Batch: 16682515 18351959 19879547 16954904 18518065 20221526 17023624 18662849 20491742 17174677 18689958 20593965 17547901 18773158 20703428 17634224 18821699 20798225 17797370 18898592 20824604 17881031 19103570 20872724 17990643 19134817 20995561 18006579 19185066 21055681 18141765 19235546 21101919 18280356 19368679 21179390
Quantity recalled1480

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1100-2018
FDA event ID
79424
Recalling firm
Boston Scientific, Marlborough, MA
Classification
Class II
Status
Terminated
Recall initiated
12 Dec 2017
FDA classified
18 Mar 2018
Reported
28 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

12 Dec 2017Recall initiated by company
18 Mar 2018Classified by FDA+96 days
28 Mar 2018Published in enforcement report+10 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Certain Malecot Nephrostomy Catheters are breaking at the mid-shaft bond during use.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Malecot Nephrostomy Catheter Set, Product Number: M0064101000, GTIN: 08714729005261 The Malecot Nephrostomy Catheter Set is intended to establish percutaneous nephrostomy drainage and is indicated for the following: Diagnostic Indications: " Antegrade pyelography " Pressure/perfusion study (Whitaker test) Therapeutic Indications: " Nephrostomy catheter drainage " Perfusion chemolysis of renal stones " Percutaneous nephrolithotomy " Percutaneous resection and coagulation of urothelial tumors

Where it was distributed

Worldwide Distribution: US (nationwide) in the following: AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KA, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, including the District of Columbia and Puerto Rico; and countries of: Argentina, Bolivia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Panama, Peru, Venezuela, Australia, Bangladesh, Botswana, China, Kuwait, Lebanon, Macau, Malaysia, Philippines, Saudi Arabia, Singapore, South Africa, South Korea, Turkey, United Arab Emirates, and Zimbabwe.

Nationwide AlabamaArkansasArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaIowaIllinoisIndianaKentuckyLouisianaMassachusettsMarylandMaineMichiganMinnesota

Questions about this recall

Why was it recalled?

Certain Malecot Nephrostomy Catheters are breaking at the mid-shaft bond during use.

Which lots are affected?

Expiration Date Range: 1/22/2018 - 10/24/2021; Batch: 16682515 18351959 19879547 16954904 18518065 20221526 17023624 18662849 20491742 17174677 18689958 20593965 17547901 18773158 20703428 17634224 18821699 20798225 17797370 18898592 20824604 17881031 19103570 20872724 17990643 19134817 20995561 18006579 19185066 21055681 18141765 19235546 21101919 18280356 19368679 21179390

Where was it sold?

Worldwide Distribution: US (nationwide) in the following: AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KA, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, including the District of Columbia and Puerto Rico; and countries of: Argentina, Bolivia, Brazil, Canada, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Panama, Peru, Venezuela, Australia, Bangladesh, Botswana, China, Kuwait, Lebanon, Macau, Malaysia, Philippines, Saudi Arabia, Singapore, South Africa, South Korea, Turkey, United Arab Emirates, and Zimbabwe.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 79424

This product is part of a recall event; the main page for the event is Percutaneous Access Set, Product Number: M0064201150 recalled.

More recalls from Boston Scientific

All 626

Other Heart & Vascular Devices recalls

All 6,199